and related product Synjardy (empagliflozin and metformin) have been cleared by the FDA for use in children aged 10 years and over with type 2 diabetes in combination with diet and exercise.

Metformin is an insulin sensitizer that effectively acts against insulin resistance, one of the predominant metabolic defects in T2DM. A combination of repaglinide and metformin is indicated as an ...

Eli Lilly and Boehringer Ingelheim’s longstanding alliance in diabetes has delivered another new product, this time a three-drug combination ... metformin hydrochloride. It adds to the Jardiance ...